High Court Rejects Apotex Fraud Case Against Merck
The U.S. Supreme Court has refused to review a lower court's rejection of Apotex Corp.'s fraud claims against Merck & Co. Inc. in the companies' long-running patent dispute over a blood...To view the full article, register now.
Already a subscriber? Click here to view full article